Send to a friend

Mr. Wilson has extensive experience in all aspects of patent litigation at both the trial and appellate levels.  His practice focuses on litigation involving biotechnology and pharmaceutical patents, with a particular emphasis on ANDA cases under the Hatch-Waxman Act.  His clients have been at the forefront of these technologies, ranging from Fortune 500 companies to small, rapidly growing start-ups.  He has also represented clients in numerous high risk cases involving “bet the company” disputes.

Represented Kali Laboratories in ANDA patent litigation relating to the anti-epilepsy drug Diastat®.  After filing the pre-trial order on non-infringement, invalidity, and inequitable conduct claims, the case settled favorably for Kali.

Represented Monsanto in a patent infringement case in which the patentee, a local public university, alleged that our client’s recombinant bovine growth hormone product infringed its patent and sought $1.8 billion in treble damages and a permanent injunction.  After eliminating one of the two accused products on summary judgment, and limiting the literal coverage of the claims to technology “known and available” in 1980, the case settled favorably the day before the jury trial was to start.

Represented Dr. Curtis Wade and HealthKomp, Inc. in mediation involving dental implants.  After a one-day hearing on claim construction, the case settled favorably for Dr. Wade.

Represented Kos Pharmaceuticals against Barr Laboratories in Paragraph IV litigation regarding Kos’ sustained release niacin product, Niaspan®.  Three related lawsuits filed over two years for infringement of four Orange Book listed patents.  Favorable settlement obtained for Kos following fact and expert discovery.

Represented Dyax Corp. in patent infringement case involving phage display libraries.  Successfully moved to dismiss for lack of personal jurisdiction in the Southern District of New York.  Obtained summary judgment of no infringement in the District of Massachusetts.  Affirmed on appeal.

Represented Vertex Pharmaceuticals against Oregon Health & Science University in declaratory judgment case involving patents related to neuroregenerative compounds.  Successfully obtained judgment on the pleadings, dismissing plaintiff’s inventorship and inequitable conduct/fraudulent procurement claims.  Remaining claims favorably settled for Vertex.

Represented Forest Laboratories and ONY Inc. against Abbott Laboratories in a case involving lung surfactant compounds.  Obtained judgment of equitable estoppel and no infringement on their behalf following a twelve-week jury trial.

Represented Pharmacia & Upjohn against American Home products in patent infringement case involving hormone replacement compositions.  Obtained favorable settlement following preliminary disclosure of invalidity contentions.

Represented Fisher Controls against Neles-Jamesbury in patent infringement case involving noise attenuating valves.  Obtained jury verdict of no infringement.  Affirmed without opinion within a week after oral argument. 
 
Represented Tessera, Inc. in patent infringement case against Texas Instruments relating to semiconductor chip packaging.  Obtained favorable settlement for Tessera two days before trial was scheduled to begin.